InfraReDx of Burlington, Mass received European CE Mark approval for its LipiScan IVUS Coronary Imaging System. Utilizing a catheter that does both ultrasound and near-infrared spectroscopy, LipiScan can be used to image the vessel lumen for plaques during angioplasty and post stenting to check how the implant is performing.
From the announcement:
In a single catheter pullback, the LipiScan IVUS provides physicians with a traditional IVUS image that clearly displays key structural parameters of the lesion, including its location, length, and degree of stenosis, in addition to confirming proper stent placement. At the same time, the system performs spectroscopic analysis of optical data to produce a Chemogram™ map that indicates the location of lipid core plaques and quantifies their lipid core burden. Integrating and co-registering the Chemogram with IVUS provides critical information to interventional cardiologists during the cardiac catheterization procedure.
Video presenting the workings of the LipiScan IVUS…
Press release: InfraReDx Receives European CE Mark Approval of LipiScan™ IVUS Coronary Imaging System
Product page: LipiScan IVUS Coronary Imaging System
Flashbacks: LipiScan Intravascular Plaque Imaging System Receives FDA 510(k) Clearance; InfraReDx Technology: Near Infrared Diffuse Spectroscopy for Coronary Artery Disease
